• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparison of Age-Related Macular Degeneration Treatments Trials 2: Introducing Comparative Effectiveness Research.

作者信息

Miller Joan W

出版信息

Ophthalmology. 2020 Apr;127(4S):S133-S134. doi: 10.1016/j.ophtha.2019.11.025.

DOI:10.1016/j.ophtha.2019.11.025
PMID:32200812
Abstract
摘要

相似文献

1
Comparison of Age-Related Macular Degeneration Treatments Trials 2: Introducing Comparative Effectiveness Research.年龄相关性黄斑变性治疗试验比较2：引入比较效果研究。
Ophthalmology. 2020 Apr;127(4S):S133-S134. doi: 10.1016/j.ophtha.2019.11.025.
2
Characteristics and Outcomes of Full-thickness Macular Hole Repair in Patients Receiving Anti-VEGF Injections for Neovascular Age-related Macular Degeneration.接受抗血管内皮生长因子注射治疗新生血管性年龄相关性黄斑变性患者的全层黄斑裂孔修复的特征及结果
Int Ophthalmol Clin. 2019 Winter;59(1):127-135. doi: 10.1097/IIO.0000000000000248.
3
PREDICTORS OF ONE-YEAR VISUAL OUTCOMES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.抗血管内皮生长因子治疗新生血管性年龄相关性黄斑变性一年后视觉预后的预测因素。
Retina. 2018 Aug;38(8):1492-1499. doi: 10.1097/IAE.0000000000001736.
4
A systematic review of the efficacy and safety outcomes of anti-VEGF agents used for treating neovascular age-related macular degeneration: comparison of ranibizumab and bevacizumab.抗血管内皮生长因子药物治疗新生血管性年龄相关性黄斑变性的疗效和安全性结局的系统评价：雷珠单抗和贝伐单抗的比较。
Curr Med Res Opin. 2011 Jul;27(7):1465-75. doi: 10.1185/03007995.2011.585394. Epub 2011 May 31.
5
Use of Bevacizumab and Ranibizumab for Wet Age-Related Macular Degeneration: Influence of CATT Results and Introduction of Aflibercept.贝伐单抗和雷珠单抗治疗湿性年龄相关性黄斑变性：CATT 研究结果的影响和阿柏西普的引入。
Am J Ophthalmol. 2019 Nov;207:385-394. doi: 10.1016/j.ajo.2019.05.011. Epub 2019 May 15.
6
Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration.在治疗新生血管性年龄相关性黄斑变性时，在雷珠单抗和阿柏西普之间转换。
Surv Ophthalmol. 2018 Sep-Oct;63(5):638-645. doi: 10.1016/j.survophthal.2018.02.004. Epub 2018 Feb 22.
7
Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two Regions.两个地区新生血管性年龄相关性黄斑变性的十年治疗结果。
Am J Ophthalmol. 2020 Feb;210:116-124. doi: 10.1016/j.ajo.2019.10.007. Epub 2019 Oct 10.
8
[Treatment of neovascular age-related macular degeneration with bevacizumab].[贝伐单抗治疗新生血管性年龄相关性黄斑变性]
Farm Hosp. 2006 Nov-Dec;30(6):387-8. doi: 10.1016/s1130-6343(06)74013-2.
9
Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis.抗血管内皮生长因子治疗视网膜疾病：系统评价和荟萃分析。
BMJ Open. 2019 May 28;9(5):e022031. doi: 10.1136/bmjopen-2018-022031.
10
New treatments for age-related macular degeneration.年龄相关性黄斑变性的新疗法。
Lancet. 2007 Oct 27;370(9597):1479-80; author reply 1480. doi: 10.1016/S0140-6736(07)61625-0.

引用本文的文献

1
Utilization of Nanoparticles for Treating Age-Related Macular Degeneration.纳米颗粒在治疗年龄相关性黄斑变性中的应用
Pharmaceuticals (Basel). 2025 Jan 25;18(2):162. doi: 10.3390/ph18020162.
2
Recent Advances in Our Understanding of Age-Related Macular Degeneration: Mitochondrial Dysfunction, Redox Signaling, and the Complement System.我们对年龄相关性黄斑变性认识的最新进展：线粒体功能障碍、氧化还原信号传导与补体系统
Aging Dis. 2024 Jan 24;16(3):1535-1575. doi: 10.14336/AD.2024.0124.
3
Deep Learning-Based Retinal Nerve Fiber Layer Thickness Measurement of Murine Eyes.
基于深度学习的鼠眼视网膜神经纤维层厚度测量。
Transl Vis Sci Technol. 2021 Jul 1;10(8):21. doi: 10.1167/tvst.10.8.21.